Cargando…
Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
Equus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 parti...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542698/ https://www.ncbi.nlm.nih.gov/pubmed/34707496 http://dx.doi.org/10.3389/fphar.2021.718154 |
_version_ | 1784589474599010304 |
---|---|
author | Zhang, Li Xu, Zhongju Jiang, Tao Zhang, Jialu Huang, Pinxian Tan, Jiaqi Chen, Gan Yuan, Man Li, Zhuo Liu, Haibin Gao, Dengfeng Xiao, Lianbo Feng, Hui Xu, Jiatuo Xu, Hongxi |
author_facet | Zhang, Li Xu, Zhongju Jiang, Tao Zhang, Jialu Huang, Pinxian Tan, Jiaqi Chen, Gan Yuan, Man Li, Zhuo Liu, Haibin Gao, Dengfeng Xiao, Lianbo Feng, Hui Xu, Jiatuo Xu, Hongxi |
author_sort | Zhang, Li |
collection | PubMed |
description | Equus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 participants were recruited and randomly allocated into the placebo control group and Ejiao-treated group (6 g/day). The primary outcomes on the efficacy of Ejiao included traditional Chinese medicine symptom scores, blood indicators, and SF-36. The secondary outcomes were changes in fireness and safety evaluation. Results showed that Ejiao treatment for 8 weeks had significantly improved dizziness symptoms. Among the tested 24 blood biochemical parameters, the hematocrit and red blood cell numbers decreased in the placebo control group, but decreased significantly less in the Ejiao treatment group. The white blood cell and neutrophil counts increased in the Ejiao group but were within the normal range. In addition, the quality of life improved as the scores in SF-36 domains were significantly higher in the Ejiao group. At the same time, there was no significant change in the fire–heat symptoms score or other safety parameters. Considering all these, our study showed that Ejiao has a promising effect in women suffering from blood deficiency without obvious adverse effects. |
format | Online Article Text |
id | pubmed-8542698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85426982021-10-26 Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial Zhang, Li Xu, Zhongju Jiang, Tao Zhang, Jialu Huang, Pinxian Tan, Jiaqi Chen, Gan Yuan, Man Li, Zhuo Liu, Haibin Gao, Dengfeng Xiao, Lianbo Feng, Hui Xu, Jiatuo Xu, Hongxi Front Pharmacol Pharmacology Equus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 participants were recruited and randomly allocated into the placebo control group and Ejiao-treated group (6 g/day). The primary outcomes on the efficacy of Ejiao included traditional Chinese medicine symptom scores, blood indicators, and SF-36. The secondary outcomes were changes in fireness and safety evaluation. Results showed that Ejiao treatment for 8 weeks had significantly improved dizziness symptoms. Among the tested 24 blood biochemical parameters, the hematocrit and red blood cell numbers decreased in the placebo control group, but decreased significantly less in the Ejiao treatment group. The white blood cell and neutrophil counts increased in the Ejiao group but were within the normal range. In addition, the quality of life improved as the scores in SF-36 domains were significantly higher in the Ejiao group. At the same time, there was no significant change in the fire–heat symptoms score or other safety parameters. Considering all these, our study showed that Ejiao has a promising effect in women suffering from blood deficiency without obvious adverse effects. Frontiers Media S.A. 2021-10-11 /pmc/articles/PMC8542698/ /pubmed/34707496 http://dx.doi.org/10.3389/fphar.2021.718154 Text en Copyright © 2021 Zhang, Xu, Jiang, Zhang, Huang, Tan, Chen, Yuan, Li, Liu, Gao, Xiao, Feng, Xu and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhang, Li Xu, Zhongju Jiang, Tao Zhang, Jialu Huang, Pinxian Tan, Jiaqi Chen, Gan Yuan, Man Li, Zhuo Liu, Haibin Gao, Dengfeng Xiao, Lianbo Feng, Hui Xu, Jiatuo Xu, Hongxi Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial |
title | Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial |
title_full | Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial |
title_fullStr | Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial |
title_full_unstemmed | Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial |
title_short | Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial |
title_sort | efficacy and safety of ejiao (asini corii colla) in women with blood deficient symptoms: a randomized, double-blind, and placebo-controlled clinical trial |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542698/ https://www.ncbi.nlm.nih.gov/pubmed/34707496 http://dx.doi.org/10.3389/fphar.2021.718154 |
work_keys_str_mv | AT zhangli efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT xuzhongju efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT jiangtao efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT zhangjialu efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT huangpinxian efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT tanjiaqi efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT chengan efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT yuanman efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT lizhuo efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT liuhaibin efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT gaodengfeng efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT xiaolianbo efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT fenghui efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT xujiatuo efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial AT xuhongxi efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial |